China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$2.37 -0.59 (-19.93%)
As of: Oct 2, 2026 · 2:21 PM EDT

China SXT Pharmaceuticals (SXTC) Change in Account Payables (2017 - 2019)

Updated

China SXT Pharmaceuticals' Change in Account Payables came in at -$693,481 for FY2026 (year ended Mar 31, 2026), compared with -$114,081 in FY2025.

Analysis

China SXT Pharmaceuticals (SXTC) Change in Account Payables (2017 - 2019) Analysis & Trends

Going back to FY2017, China SXT Pharmaceuticals' Change in Account Payables data covers 10 fiscal years.

  • The FY2026 figure represents the lowest annual Change in Account Payables since FY2017.
  • Per Business Quant, earlier fiscal years put Change in Account Payables at -$114,081 in FY2025, -$29,254 in FY2024, $9,700 in FY2023 and -$22,792 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -70.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -66.70 Mn
10 China SXT Pharmaceuticals 39,500.23 -85.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -567,313.00
Dec 31, 2018 966,573.00
Dec 31, 2017 -1.47 Mn
API Access

China SXT Pharmaceuticals Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=SXTC&period=max&api_key=YOUR_API_KEY